CD47 and cancer: Therefore, approaches using anti-CD47 or anti-SIRPα antibodies to induce phagocytosis of cancer cells by TAMs have been attempted, and it has been reported that blocking human head and neck cancer cells with CD47 and anti-CD47 antibodies increases phagocytosis by macrophages [84].